-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MdxipWD+Xemck1HXQuvK8T33ukAKTR51Sj0dnoBIhIVsINL9MxbHlB1rQSLO2ic2 LmidSutZ31n1a8UTJ9FnEQ== 0000950116-99-001216.txt : 19990624 0000950116-99-001216.hdr.sgml : 19990624 ACCESSION NUMBER: 0000950116-99-001216 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990623 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: QUIPP INC CENTRAL INDEX KEY: 0000796577 STANDARD INDUSTRIAL CLASSIFICATION: SPECIAL INDUSTRY MACHINERY, NEC [3559] IRS NUMBER: 592306191 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-37630 FILM NUMBER: 99651066 BUSINESS ADDRESS: STREET 1: 5700 N W 157TH STRRET CITY: MIAMI STATE: FL ZIP: 33014 BUSINESS PHONE: 3056238700 MAIL ADDRESS: STREET 1: 4800 NW 157 STREET CITY: MIAMI STATE: FL ZIP: 33014 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LANGONE KENNETH G CENTRAL INDEX KEY: 0000905874 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 MAIL ADDRESS: STREET 1: 375 PARK AVE CITY: NEW YORK STATE: NY ZIP: 1052 SC 13D 1 SC 13D ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (1) (Amendment No. 8) (2) Quipp, Inc. ---------------- (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 748802-10 -------------- (CUSIP Number) June 2, 1999 ------------ (Date of Event Which Requires Filing of this Statement) Kenneth G. Langone 375 Park Avenue New York, New York 10152 -------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) If the filing person has previously filed a statement on schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this Schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box |_| Note: Schedules filed in paper format shall include a signed original and two copies of the Schedule including all exhibits. See Rule 13(d)-7(b) for other parties to whom copies are to be sent. - ------------ 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. 2 This Amendment No. 8 amends that Schedule 13D, as amended, filed on behalf of Kenneth G. Langone, successor-in-interest to North-South Investors II, with the Securities and Exchange Commission on November 16, 1989. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ================================================================================ CUSIP Number 748802-10 Page 2 of 5 Pages 13D 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Kenneth G. Langone - ------ ------------------------------------------------------------------------ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) X - ------ ------------------------------------------------------------------------ 3. SEC USE ONLY - ------ ------------------------------------------------------------------------ 4. SOURCE OF FUNDS AF - ------ ------------------------------------------------------------------------ 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - ------ ------------------------------------------------------------------------ 6. CITIZENSHIP OR PLACE OF ORGANIZATION United States of America - ------ ------------------------------------------------------------------------ NUMBER OF 7. SOLE VOTING POWER SHARES 176,048 shares BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH - ----------------------- ------- ------------------------------------------------ 8. SHARED VOTING POWER 0 - ----------------------- ------- ------------------------------------------------ 9. SOLE DISPOSITIVE POWER 176,048 - ----------------------- ------- ------------------------------------------------ 10. SHARED DISPOSITIVE POWER 0 - ----------------------- ------- ------------------------------------------------ 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 176,048 - ------ ------------------------------------------------------------------------ 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - ------ ------------------------------------------------------------------------ 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.3 % - ------ ------------------------------------------------------------------------ 14. TYPE OF REPORTING PERSON* IN - ------ ------------------------------------------------------------------------ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP Number 748802-10 Page 3 of 5 Pages Schedule 13D Item 3. Source and Amount of Funds or other Consideration In May and June of 1999, Invemed Associates LLC conducted the following open market transactions:
Date Purchased No. Shares Purchased Price Per Share Total Consideration -------------- -------------------- --------------- ------------------- May 11 1,000 $ 14 $ 14,000 May 12 1,100 14 15,400 May 13 250 14 3,500 May 14 3,000 14 42,000 May 18 2,000 14 28,000 May 19 2,000 14 28,000 May 21 900 14 12,600 May 24 600 13.875 8,325 May 26 3,348 13.875 46,453.5 May 27 3,600 13.875 49,950 June 1 1,000 13.9375 13,937.5 June 2 1,400 13.9375 19,512.5 June 3 2,500 13.75 34,375 June 4 2,000 13.75 27,500 June 11 2,000 13.375 26,750 June 14 1,350 13.375 18,056.25 June 15 1,500 13.25 19,875
An aggregate total of $408,234.75 was disbursed as consideration in the aforementioned transactions. All such funds were obtained from the working capital of Invemed Associates LLC. Item 4. Purpose of Transactions. Acquisition of securities of the issuer by Invemed Associates LLC is for investment purposes only. There are no plans or proposals for the acquisition of securities of the issuer other than for investment purposes. CUSIP Number 748802-10 Page 4 of 5 Pages Item 5. Interest in Securities of the Issuer. (a) Kenneth G. Langone beneficially owns 176,048 shares of Quipp, Inc. Common Stock, which is 9.3% of the aggregate total of Quipp, Inc. Common Stock outstanding. Such amount includes 74,948 shares of Quipp, Inc. Common Stock owned by Invemed Associates LLC. Mr. Langone owns 81% of Invemed Associates LLC and is the managing director. (b) Mr. Langone has sole power to vote or direct the vote of the reported shares of Quipp Common Stock. Mr. Langone has sole power to dispose of or direct the disposition of the reported shares of Quipp Common Stock. (c) Except as set forth in this amendment, Mr. Langone is not aware, to the best of his knowledge, of any other reportable transactions up to the filing date of this amendment. CUSIP Number 748802-10 Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. June 21, 1999 ------------------ (Date) /s/ Kenneth G. Langone --------------------------- (Signature) Kenneth G. Langone --------------------------- (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----